Molecular modelling of hepatitis B virus polymerase: Comparison of adefovir, entecavir and lamivudine resistance

被引：0
|
作者：
Bartholomeusz, A
Locarnini, S
Colledge, D
Ayres, A
Kuiper, M
Chalmers, D
机构：
[1] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[2] Victorian Partnership Adv Comp, Melbourne, Vic, Australia
[3] Vic Coll Pharm, Parkville, Vic, Australia
来源：
ANTIVIRAL RESEARCH | 2004年 / 62卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
49
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [21] Molecular modelling of entecavir resistant mutations in the hepatitis B virus polymerase selected during therapy
    Warner, N
    Locarnini, SA
    Edwards, R
    Angus, P
    Sievert, W
    Kuiper, M
    Chalmers, D
    Bartholomeusz, A
    HEPATOLOGY, 2004, 40 (04) : 245A - 245A
  • [22] Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudine
    Marugan, RB
    Gomez, LC
    Serrano, PL
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) : 1841 - 1843
  • [23] THE COMPARISON OF THREE RESCUE TREATMENT STRATEGIES FOR LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B: LAMIVUDINE AND ADEFOVIR COMBINATION THERAPY, ENTECAVIR MONOTHERAPY, AND ADEFOVIR MONOTHERAPY
    Jang, Eun Sun
    Lee, Jeong-Hoon
    Yoon, Jung-Hwan
    Cho, Eun Ju
    Yang, Hyo-Joon
    Kwak, Min-Sun
    Ahn, Dong-Won
    Hwang, Sang Youn
    Yu, Su Jong
    Lee, Chang-Hoon
    Kim, Yoon Jun
    Lee, Hyo-Suk
    HEPATOLOGY, 2010, 52 (04) : 520A - 520A
  • [24] Comparison of entecavir and adefovir for the treatment of chronic hepatitis B
    Zhao, Si-Hai
    Liu, En-Qi
    Cheng, Da-Xin
    Li, Ya-Feng
    Wang, Yan-Li
    Chen, Yu-Long
    Sun, Wen-Tao
    Yan, Xi-Cai
    Dang, Shuang-Suo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (04): : 366 - 372
  • [25] Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro
    Xiong, XF
    Flores, C
    Yang, H
    Toole, JJ
    Gibbs, CS
    HEPATOLOGY, 1998, 28 (06) : 1669 - 1673
  • [26] The combination of lamivudine and adefovir prevents both lamivudine and adefovir resistance in patients with chronic hepatitis B
    Hezode, Christophe
    Dhalluin-Venier, Valerie
    Chevaliez, Stephane
    Roudot-Thoraval, Francoise
    Mallat, Ariane
    Pawlotsky, Jean-Michel
    GASTROENTEROLOGY, 2008, 134 (04) : A810 - A810
  • [27] Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: Clonal evolution during lamivudine plus adefovir therapy
    Kim, Soon Sun
    Cho, Sung Won
    Kim, Soo-Ok
    Hong, Sun Pyo
    Cheong, Jae Youn
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (01) : 55 - 64
  • [28] Rescue Therapy for Lamivudine-resistant Chronic Hepatitis B: Adefovir Monotherapy, Adefovir Plus Lamivudine or Entecavir Combination Therapy
    Ha, Minghao
    Zhang, Guotong
    Diao, Shu
    Lin, Mingfang
    Wu, Jianqiu
    Sun, Liping
    She, Huiyuan
    Shen, Lihui
    Huang, Chunhong
    Shen, Wenjuan
    Huang, Zhongming
    INTERNAL MEDICINE, 2012, 51 (12) : 1509 - 1515
  • [29] Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir
    Son, Chang Young
    Ryu, Han Jak
    Lee, Jung Min
    Ahn, Sang Hoon
    Kim, Do Young
    Lee, Myoung Ha
    Han, Kwang Hyub
    Chon, Chae Yoon
    Park, Jun Yong
    LIVER INTERNATIONAL, 2012, 32 (07) : 1179 - 1185
  • [30] COMPARISON ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY WITH ADEFOVIR MONOTHERAPY IN LAMIVUDINE RESISTANT CHRONIC HEPATITIS B
    Park, Woo Young
    Hwang, Jaeseok
    Jang, Byoung Kuk
    Shin, Jung Woo
    Park, Neung Hwa
    Lee, Byung Seok
    Lee, Joon Hyoek
    Bae, Si Hyun
    Tak, Won Young
    Lee, June Sung
    Lee, Chun Kyon
    Baik, Soon Koo
    Lee, Tae Hee
    Lee, Youn Jae
    HEPATOLOGY, 2009, 50 (04) : 531A - 532A
12345